Relief Today. Healthier Tomorrow.
Broad-spectrum antifungal agents and keratolytic corticosteroid combinations designed for rapid relief from fungal infections and stubborn psoriatic plaques.

Eberconazole 1% · Ketoconazole 2% · Luliconazole 1% · Clobetasol + Salicylic Acid
Each product is manufactured in compliance with international cGMP standards and verified by HPLC assay.
DermaGenesis has therapeutic dossiers currently under active phase trial and stability testing in this discipline. Registered dermatologists can contact Medical Affairs for pipeline monograph access.
High-affinity ergosterol biosynthesis inhibition disrupts fungal cell membranes, while synergistic keratolytic action breaks down hyperkeratotic plaque scale.
Rapid mycological clearance and pruritus suppression within 72 hours.
Thins hyperkeratotic plaques and eliminates silvery scaling.
Controls Malassezia fungal overgrowth on scalp and facial folds.
Clears fungal colonization in intertriginous areas.
Apply a thin layer covering the lesion and 1 inch of healthy perimeter.
Continue therapy for direct prescribed duration to prevent recurrence.
Keep affected areas clean and completely dry before application.